Daewoong Targets Mass Market with KRW3,000 Supplements via Daiso Amid Pharmacy Pressure
South Korean pharmaceutical giant Daewoong is challenging traditional supplement distribution by selling low-cost health functional foods in Daiso, undercutting market prices by up to seven times. This move signals a strategic shift towards mass-market affordability, despite industry opposition.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
Seoul, South Korea — 11 April 2025
South Korea's Daewoong Pharmaceutical is executing a mass-market strategy by distributing health functional foods through the budget retail chain Daiso. This initiative involves selling 26 products under the 'Dr.Bear' brand across 200 Daiso Korea stores since 24 February. Products are priced at KRW3,000 to KRW5,000 (USD2 to USD3.50) per month, presenting a significant disruption to established market pricing, which typically ranges from KRW20,000 to KRW30,000 (USD14 to USD21). This move, despite reported pressure from the wider pharmacy sector, underscores a drive to capture the affordable supplement market segment.
The emphasis on value extends beyond pricing, as evidenced by Singapore's Re-erth, which has launched new formulations like 'Phytobright+' to offer enhanced benefits to value-conscious consumers. This responds to evolving consumer spending habits influenced by readily available, discounted quality products across online and offline channels.
Meanwhile, sustainability and ethical sourcing are becoming critical competitive differentiators. Blackmores Group has achieved B Corp certification for all its brands, including BioCeuticals and Pure Animal Wellbeing. This certification addresses increasing consumer expectations for environmental, social, and governance (ESG) performance and strengthens supply chain resilience. Head of Sustainability, Sally Townsend, noted B Corp's rising importance in Asia, particularly among younger consumers.
Market expansion continues, with Australia's Vincent entering the US with a skincare and dietary supplement line, available via its website and Amazon. Concurrently, Singaporean start-up Altimate Nutrition has launched cricket protein bars in retail channels after nearly four years awaiting regulatory approval, actively seeking distributors to scale its novel protein offerings.
What this means for South Korea
Manufacturers and brand owners in South Korea face immediate pressure on pricing and distribution models. Daewoong's direct-to-mass-retail strategy with sub-KRW5,000 products necessitates a re-evaluation of product portfolio tiering and channel partnerships for competitors. Compliance teams should monitor potential regulatory responses or lobbying from pharmacy associations regarding OTC supplement sales. Procurement leads must assess raw material costs to compete at these new price points, potentially requiring formulation adjustments or larger MOQs to maintain viability. Opportunities exist for agile brands to innovate with value-driven formulations or differentiate via strong ESG credentials to capture distinct consumer segments.
For more on UK formulation and manufacturing best practice, learn more at Supplement Factory.